Evidence map›Paper›PMID 23222662›Full record

ReviewGenetics in medicine : official journal of the American College of Medical Genetics2013

Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework.

Beth K Potter, Pranesh Chakraborty, Jonathan B Kronick, Kumanan Wilson, Doug Coyle, Annette Feigenbaum, Michael T Geraghty, Maria D Karaceper, Julian Little, Aizeddin Mhanni and 5 more

Abstract readReview
In one paragraph

Review in Genetics in medicine : official journal of the American College of Medical Genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Literature Review on Health Emigration in Rare Diseases-A Machine Learning Perspective.International journal of environmental research and public health · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Clinical utility of genetic and genomic services: context matters.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  15. Review
  16. Article
  17. Article
  18. Newborn bloodspot screening policy framework for Australia.The Australasian medical journal · 2015
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Beth K PotterDepartment of Epidemiology & Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. bpotter@uottawa.ca
Pranesh Chakraborty
Jonathan B Kronick
Kumanan Wilson
Doug Coyle
Annette Feigenbaum
Michael T Geraghty
Maria D Karaceper
Julian Little
Aizeddin Mhanni
John J Mitchell
Komudi Siriwardena
Brenda J Wilson
Ania Syrowatka
Canadian Inherited Metabolic Diseases Research Network

Funding

Canadian Institutes of Health Research TR3-119195
6 · The paper itself

Abstract

Across all areas of health care, decision makers are in pursuit of what Berwick and colleagues have called the "triple aim": improving patient experiences with care, improving health outcomes, and managing health system impacts. This is challenging in a rare disease context, as exemplified by inborn errors of metabolism. There is a need for evaluative outcomes research to support effective and appropriate care for inborn errors of metabolism. We suggest that such research should consider interventions at both the level of the health system (e.g., early detection through newborn screening, programs to provide access to treatments) and the level of individual patient care (e.g., orphan drugs, medical foods). We have developed a practice-based evidence framework to guide outcomes research for inborn errors of metabolism. Focusing on outcomes across the triple aim, this framework integrates three priority themes: tailoring care in the context of clinical heterogeneity; a shift from "urgent care" to "opportunity for improvement"; and the need to evaluate the comparative effectiveness of emerging and established therapies. Guided by the framework, a new Canadian research network has been established to generate knowledge that will inform the design and delivery of health services for patients with inborn errors of metabolism and other rare diseases.

Indexed as

Disease ManagementMetabolism, Inborn ErrorsOutcome Assessment, Health CareEvidence-Based PracticeHumans

Identifiers

PMID23222662
PMCPMC3837195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.